概括
抗精神病药物可能会影响精神分裂症谱系障碍 (SSD) 患者的生物衰老. 多种药物显示出一些衰老减缓,特别是在女性中,但效果并不依赖于剂量.
科学领域:
- 精神病学是一个精神病学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 衰老研究研究 衰老研究
背景情况:
- 精神分裂症谱系障碍 (SSD) 需要综合管理,通常涉及具有副作用的抗精神病药物.
- 新出现的证据将SSD与表观遗传衰老变化联系起来,但抗精神病治疗的影响尚不清楚.
研究的目的:
- 在153名SSD患者中调查抗精神病药物和表观遗传衰老加速 (EAA) 之间的关联.
- 探索抗精神病药物对EAA的潜在性别特异性影响和剂量依赖关系.
主要方法:
- 用6个表观遗传时钟测量EAA,该时钟基于外围血液细胞中的DNA甲基化模式.
- 分析包括抗精神病单药和多药之间的比较,性别特异性分析和剂量标准化方法.
主要成果:
- 接受抗精神病药物多种药物治疗的个体表现出衰老减缓的趋势 (汉纳姆DNAm年龄,p=0.0109).
- 性别特定的分析显示,在三个时钟的多药性治疗中,女性的表观遗传衰老显著减缓.
- 没有观察到抗精神病药对EAA的剂量依赖性影响.
结论:
- 抗精神病治疗可能会调节SSD中的生物衰老,并可能对性别产生特定的影响.
- 观察到的衰老调节并不依赖于剂量,这表明了复杂的相互作用.
- 进一步的研究对于了解SSD中抗精神病药物管理的益处和风险至关重要.
相关概念视频
Psychosis: Goals of Pharmacotherapy
457
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
457
Psychosis and Antipsychotic Drugs: Overview
795
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
795
Pharmacodynamics in Geriatric Patients: Effects of Age
182
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
182
Drug Therapy
237
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
237
Biological Causes of Schizophrenia
479
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
479
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K


